Results 31 to 40 of about 1,246 (182)
Highly thrombogenic phenotype and impaired wound healing in a patient with congenital dysfibrinogenemia: case report. [PDF]
Background: Congenital fibrinogen disorders are classified based on both fibrinogen levels and the clinical phenotype. For dysfibrinogenemia, normal fibrinogen levels are typical.
El Beayni N +4 more
europepmc +2 more sources
Diagnostic value of clot formation parameters determined by rotational thromboelastometry in 63 patients with congenital dysfibrinogenemia. [PDF]
Rotational thromboelastometry (ROTEM) is a global hemostasis assay. The diagnosis added value of ROTEM in congenital dysfibrinogenemia remains to be established.
Simurda T +11 more
europepmc +2 more sources
Multiple Myeloma Presenting as Lower Gastrointestinal Bleeding: A Case Report. [PDF]
ABSTRACT Multiple myeloma (MM) is a malignant hematologic neoplasm that primarily affects the bone marrow and can invade other organs, leading to diverse clinical manifestations. Presentation with gastrointestinal bleeding as the initial symptom is exceptionally rare.
Arabi A +4 more
europepmc +2 more sources
The Swiss Haemophilia Registry-Report From the First 8 Years. [PDF]
ABSTRACT Introduction Patient registries capture disease related information and provide a valuable source for real‐world data on rare diseases and their management. The Swiss Haemophilia Registry (SHR) was established in 2015 on the basis of a new Swiss federal human research act.
Bosch A +8 more
europepmc +2 more sources
Dysfibrinogenemia-Potential Impact of Genotype on Thrombosis or Bleeding
The congenital dysfibrinogenemias, most often associated with bleeding disorders, encompass mutations in the amino-terminal end of fibrinogen α-chain consisting of Gly17-Pro18-Arg19-Val20, known as knob A, which is a critical site for fibrin ...
Feddersen, Søren +7 more
core +1 more source
Turbidity analysis is widely used as a quantitative technique in hereditary dysfibrinogenemia. We aimed to compare several coagulation triggers in hereditary dysfibrinogenemia and control plasmas. We included 20 patients with hereditary dysfibrinogenemia,
Christine Mouton +17 more
core +1 more source
Validating the Online Self-Administered Bleeding Assessment Tool (Self-BAT) as a Screening Tool for Bleeding Disorders. [PDF]
Haemophilia, Volume 32, Issue 1, Page 324-327, January/February 2026.
DeYoung V +5 more
europepmc +2 more sources
Acquired dysfibrinogenemia caused by monoclonal production of immunoglobulin λ light chain
Disorders of fibrinogen are usually caused by genetic mutations that result in low protein levels (hypofibrinogenemia) or an abnormal molecule (dysfibrinogenemia). However, environmental and plasma factors can have an acquired effect on its expression or
A. Dear +4 more
doaj +1 more source

